Skip to content
Home/Companies/Biotech/Cambrium
CA

Cambrium

Biotech·Germany·Active·6yr hold

Cambrium is a biotech company, headquartered in Germany.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Cambrium?

Cambrium is currently owned by Merantix Capital through Merantix Capital Fund I (2020 vintage), since 2020. Across its history, Cambrium has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Merantix Capital
Most recent investor
Merantix Capital
Merantix Capital Fund I · 2020 · VC
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Merantix Capital and Redstone since 2020.
Co-invest · 2 holders · 2020 · present
Merantix Capital
Merantix CapitalActive
2020 · present · Merantix Capital Fund I · 2020 · VC
MOIC
–
Redstone
RedstoneActive
2025 · present · Redstone Ventures · 2014 · Evergreen
MOIC
–

More from Merantix Capital Fund I

Other portfolio companies in the same fund.

Libra
Exited 2025
SoftwareGermany· 2023
to
Ovom Care
Active
HealthcareGermany· 2023
Deltia
Active
IndustrialsGermany· 2022
Briink
Active
SoftwareGermany· 2021
Kausa
Exited 2023
SoftwareGermany· 2021
to
SiaSearch
Exited 2021
SoftwareGermany· 2019
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings